Try our beta test site
431 studies found for:    cachexia
Show Display Options
Rank Status Study
1 Recruiting Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia
Conditions: Cachexia;   NSCLC
Interventions: Dietary Supplement: Nutrifriend Cachexia;   Dietary Supplement: Isocaloric placebo
2 Completed Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in COPD Cachexia
Conditions: COPD;   Cachexia
Interventions: Dietary Supplement: Nutrifriend Cachexia;   Dietary Supplement: Isocaloric placebo
3 Completed A Clinical Study With MT-102 in Subjects With Cancer Cachexia
Condition: Cancer Cachexia
Intervention: Drug: MT-102
4 Terminated
Has Results
The Role of Ghrelin in Cancer Cachexia
Condition: Cancer Cachexia
Interventions: Drug: Anamorelin HCl;   Drug: Placebo
5 Recruiting Brown Adipose Tissue Activity and Energy Metabolism in Cachexia
Conditions: Cachexia;   Neoplasms;   Pulmonary Disease, Chronic Obstructive;   Pancreatic Neoplasms
Interventions: Radiation: 18F-FDG PET-MRI-imaging;   Radiation: DXA scanning;   Procedure: Abdominal subcutaneous adipose tissue biopsy;   Procedure: Blood sampling;   Other: Indirect calorimetry;   Device: Accelerometry;   Other: Double-labeled water
6 Unknown  Lenalidomide for Lean Body Mass and Muscle Strength in Inflammatory Cancer Cachexia Syndrome
Condition: Cancer Cachexia Syndrome
Interventions: Drug: Lenalidomide;   Other: basic cachexia management (prokinetics, physical activity counselling, nutritional counselling)
7 Completed Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer.
Conditions: Non-small Cell Lung Cancer;   Cachexia
8 Completed Pilot Study of APD209 in Cancer Cachexia
Condition: Cancer-related Cachexia
Intervention: Drug: APD209
9 Completed Insulin Treatment in Cancer Cachexia
Condition: Cancer Cachexia
Intervention: Drug: Insulatard, flexpen
10 Completed SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Cachexia
Interventions: Drug: Placebo comparator;   Drug: SUN11031
11 Completed Enteral Nutrition in Congestive Heart Failure and Cardiac Cachexia
Conditions: Chronic Heart Failure;   Cardiac Cachexia
Interventions: Dietary Supplement: NutriDrink;   Dietary Supplement: Placebo
12 Completed
Has Results
A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
Condition: Cancer Cachexia
Intervention: Drug: Eicosapentaenoic Acid
13 Completed
Has Results
Regimen for the Treatment of Cachexia in Subjects With NSCLC
Condition: Cachexia
Interventions: Drug: VT-122 low dose;   Drug: VT-122 high dose
14 Completed Prevalence of Cachexia in Patients Undergoing Chemotherapy
Conditions: Cancer;   Cachexia
15 Recruiting Food Reward in Cachexia Induced by Acute or Chronic Disease
Conditions: Cachexia;   Chronic Obstructive Pulmonary Disease;   Non-small Cell Lung Cancer;   Pancreatic Cancer
Intervention: Other: Functional magnetic resonance imaging (fMRI)
16 Completed
Has Results
Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
Condition: Cachexia
Interventions: Drug: GTx-024;   Drug: Placebo
17 Completed
Has Results
BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia
Condition: Chronic Obstructive Pulmonary Disease (COPD) With Cachexia
Interventions: Drug: Placebo;   Drug: BYM338
18 Recruiting A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia
Condition: Cancer Cachexia
Intervention: Drug: Kanglaite Injection
19 Terminated Protein-energy Oral Supplementation Enriched With Omega-3 Fatty Acids in Cardiac Cachexia
Condition: Cardiac Cachexia
Interventions: Dietary Supplement: Fortimel Extra®;   Dietary Supplement: Fortimel Care®
20 Recruiting Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia
Condition: Cancer Cachexia
Interventions: Drug: Macimorelin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.